Genoway operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genoway with three other
companies in this sector in France:
Ose Immunotherapeutics SA
sales of 6.68 million Euro [US$8.27 million]
(6.52 million Euro [US$8.07 million]
(6.86 million Euro [US$8.49 million]
During the year ended December of 2017, sales at
Genoway were 9.90 million Euro (US$12.25 million).
increase of 9.1%
versus 2016, when the company's sales were 9.08 million Euro.
This was the fifth consecutive year of sales increases at Genoway
(and since 2012, sales have increased a total of 34%).